Market
Understand market structure changes, launch dynamics, and access shifts that affect asset and company valuations.
5 signals
STRATEGY
HPV vaccine hesitancy among female university students in China rose from 8.8% to 21.6% between 2022 and 2025, despite improved knowledge.
STRATEGY
The review identifies uneven HPV vaccination coverage across SEAR countries, with significant barriers to implementation.
STRATEGY
Lilly's Q1 2026 revenue surged 56% to $19.8 billion, driven by strong volume growth despite lower prices for Mounjaro and Zepbound.
STRATEGY
A comprehensive review identifies socio-cultural and trust-related factors influencing HPV vaccine hesitancy.
STRATEGY
A novel non-aqueous rotavirus vaccine formulation demonstrates significant thermostability and ease of administration, suitable for ambient shipping.
Showing 1–5 of 5 records
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.